Sound Income Strategies LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 85.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 242,064 shares of the medical instruments supplier's stock after purchasing an additional 111,199 shares during the quarter. Sound Income Strategies LLC owned about 0.12% of DENTSPLY SIRONA worth $4,594,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC raised its position in shares of DENTSPLY SIRONA by 33.2% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 17,232 shares of the medical instruments supplier's stock valued at $428,000 after acquiring an additional 4,296 shares during the period. Canada Pension Plan Investment Board bought a new position in shares of DENTSPLY SIRONA during the second quarter worth $3,527,000. Pacer Advisors Inc. boosted its position in shares of DENTSPLY SIRONA by 116.6% during the second quarter. Pacer Advisors Inc. now owns 31,160 shares of the medical instruments supplier's stock worth $776,000 after purchasing an additional 16,776 shares in the last quarter. Sei Investments Co. grew its holdings in shares of DENTSPLY SIRONA by 32.2% in the 2nd quarter. Sei Investments Co. now owns 572,537 shares of the medical instruments supplier's stock valued at $14,262,000 after buying an additional 139,578 shares during the period. Finally, Thrivent Financial for Lutherans increased its position in shares of DENTSPLY SIRONA by 8.5% in the 2nd quarter. Thrivent Financial for Lutherans now owns 353,194 shares of the medical instruments supplier's stock valued at $8,798,000 after buying an additional 27,708 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the stock. Evercore ISI reaffirmed an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Morgan Stanley lowered their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday, December 17th. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Finally, UBS Group dropped their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research report on Tuesday, December 3rd. Ten investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Hold" and a consensus price target of $26.67.
Check Out Our Latest Stock Report on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Up 0.5 %
XRAY traded up $0.09 during trading on Friday, reaching $19.53. 2,671,115 shares of the stock were exchanged, compared to its average volume of 2,495,604. The stock has a market cap of $3.88 billion, a P/E ratio of -9.43, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock's 50 day moving average price is $18.98 and its two-hundred day moving average price is $22.74. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $35.68.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million for the quarter, compared to analysts' expectations of $939.10 million. During the same period in the prior year, the firm earned $0.49 EPS. DENTSPLY SIRONA's quarterly revenue was up .4% compared to the same quarter last year. Equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.
DENTSPLY SIRONA Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.28%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's payout ratio is presently -30.92%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.